DRIO (DarioHealth) Float Percentage Of Total Shares Outstanding : 90.80% (As of Mar. 23, 2025)

View and export this data going back to 2013. Start your Free Trial

What is DarioHealth Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DarioHealth's float shares is 37.75 Mil. DarioHealth's total shares outstanding is 41.57 Mil. DarioHealth's float percentage of total shares outstanding is 90.80%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DarioHealth's Insider Ownership is 17.12%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DarioHealth's Institutional Ownership is 20.21%.

DarioHealth Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

DarioHealth's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	37.75	/	41.57
	=	90.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DarioHealth Corp (NAS:DRIO) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

322 W. 57th Street, New York, NY, USA, 10019

Website

https://www.mydario.com

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Executives

Erez Raphael	director, officer: Chief Executive Officer	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Jon H. Kaplan	director	1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Dennis M Mcgrath	director	C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165
Dror Bacher	officer: Chief Operating Officer	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK L3 3088900
Oded Cohen	officer: GM MSK	8 HATOKHEN ST., CAESAREA INDUSTRIAL PARK L3 3088900
Adam K Stern	director	STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Dennis Matheis	director	8 HATOKHEN ST., CAESAREA L3 38900
Yoav Shaked	director	8 HATOKHEN ST., CAESAREA L3 3088900
Yadin Shemmer	director	8 HATOKHEN ST., CAESAREA L3 3088900
Richard Allan Anderson	officer: President, GM of North America	C/O DARIOHEALTH CORP., 18 W. 18TH ST, 5TH FLOOR, NEW YORK NY 10011
Yalon Farhi	director	C/O LABSTYLE INNOVATIONS CORP., 9 HALAMISH ST., CAESAREA INDUSTRIAL PARK, CAESAREA L3 3088900
Hila Karah	director	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Zvi Ben-david	officer: Chief Financial Officer	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Glen Moller	director	8 HATOKHEN ST., CAESAREA L3 3088900
Olivier Roger Jarry	officer: See Remarks	15 ROCKRIDGE RD, LARCHMONT NY 10538-3918